The Association between Meibomian Gland Atrophy and Corneal Subbasal Nerve Loss in Patients with Chronic Ocular Graft-versus-host Disease

References

• Hessen M, Akpek EK. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol. 2012;12:540–47.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam SC, Raja H, Nau CB, Shen JF, Schornack MM. Ocular Graft-Versus-Host Disease: A Review. Eye Contact Lens. 2015;41:256–61.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, Ono M, Yang HY, Mashima Y, Oguchi Y. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125–30.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Bernabei F, Scorcia V, Campos E. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol. 2019;257:1341–51.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, Perez VL, Shikari H, Riemens A, Tsubota K. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013;3:3419.
   PubMed Web of Science ®Google Scholar
• Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:233–51.
   PubMed Web of Science ®Google Scholar
• Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, Garcia-Sanchez J. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48:173–81.
   PubMed Web of Science ®Google Scholar
• Kheirkhah A, Qazi Y, Arnoldner MA, Suri K, Dana R. In Vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease. Invest Ophthalmol Vis Sci. 2016;57:4686–91.
   PubMed Web of Science ®Google Scholar
• Kheirkhah A, Rahimi Darabad R, Cruzat A, Hajrasouliha AR, Witkin D, Wong N, Dana R, Hamrah P. corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot In Vivo confocal microscopic study. Invest Ophthalmol Vis Sci. 2015;56:7179–85.
   PubMed Web of Science ®Google Scholar
• Steger B, Speicher L, Philipp W, Bechrakis NE. In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol. 2015;99:160–65.
   PubMed Web of Science ®Google Scholar
• Tepelus TC, Chiu GB, Maram J, Huang J, Chopra V, Sadda SR, Lee OL. Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol. 2017;255:2389–97.
   PubMed Web of Science ®Google Scholar
• Villani E, Galimberti D, Viola F, Mapelli C, Ratiglia R. The cornea in Sjogren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48:2017–22.
   PubMed Web of Science ®Google Scholar
• Villani E, Magnani F, Viola F, Santaniello A, Scorza R, Nucci P, Ratiglia R. In vivo confocal evaluation of the ocular surface morpho-functional unit in dry eye. Optom Vis Sci. 2013;90:576–86.
   PubMed Web of Science ®Google Scholar
• Benitez Del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci. 2004;45:3030–35.
   PubMed Web of Science ®Google Scholar
• He J, Ogawa Y, Mukai S, Saijo-Ban Y, Kamoi M, Uchino M, Yamane M, Ozawa N, Fukui M, Mori T, et al. In Vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep. 2017;7:10720.
   PubMed Web of Science ®Google Scholar
• Al-Aqaba MA, Dhillon VK, Mohammed I, Said DG, Dua HS. Corneal nerves in health and disease. Prog Retin Eye Res. 2019;73:100762.
   PubMed Web of Science ®Google Scholar
• Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409–16.
   PubMed Web of Science ®Google Scholar
• Kheirkhah A, Coco G, Satitpitakul V, Dana R. Subtarsal fibrosis is associated with ocular surface epitheliopathy in graft-versus-host disease. Am J Ophthalmol. 2018;189:102–10.
   PubMed Web of Science ®Google Scholar
• Arain MA, Niazi MK, Khan MD, Ahmed P, Naz MA, Fayyaz M. Frequency of ocular manifestations of chronic graft versus host disease. J Ayub Med Coll Abbottabad. 2010;22:80–83.
   PubMedGoogle Scholar
• Ogawa Y. Sjogren’s syndrome, non-Sjogren’s syndrome, and graft-versus-host disease related dry eye. Invest Ophthalmol Vis Sci. 2018;59:71–79.
   Web of Science ®Google Scholar
• Ban Y, Ogawa Y, Ibrahim OM, Tatematsu Y, Kamoi M, Uchino M, Yaguchi S, Dogru M, Tsubota K. Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis. 2011;17:2533–43.
   PubMed Web of Science ®Google Scholar
• Engel LA, Wittig S, Bock F, Sauerbier L, Scheid C, Holtick U, Chemnitz JM, Hallek M, Cursiefen C, Steven P. Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transplant. 2015;50:961–67.
   PubMed Web of Science ®Google Scholar
• Kim S, Yoo YS, Kim HS, Joo CK, Na KS. Changes of meibomian glands in the early stage of post hematopoietic stem cell transplantation. Exp Eye Res. 2017;163:85–90.
   PubMed Web of Science ®Google Scholar
• Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401 e381.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.
   PubMed Web of Science ®Google Scholar
• Lew H, Kim CH, Yun YS, Han SH. Binocular photophobia after surgical treatment in intermittent exotropia. Optom Vis Sci. 2007;84:1101–03.
   PubMed Web of Science ®Google Scholar
• Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–50.
   PubMed Web of Science ®Google Scholar
• Pult H, Riede-Pult B. Comparison of subjective grading and objective assessment in meibography. Cont Lens Anterior Eye. 2013;36:22–27.
   PubMed Web of Science ®Google Scholar
• Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006;17:344–48.
   PubMed Web of Science ®Google Scholar
• Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR. Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations. J Ophthalmic Vis Res. 2013;8:351–58.
   PubMedGoogle Scholar
• Rumery TC, Mian SI. Ocular graft vs. host disease after hematopoietic stem cell transplantation. Insight. 2013;38:11–18.
   PubMedGoogle Scholar
• Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea. 2003;22:S19–27.
   PubMed Web of Science ®Google Scholar
• Inamoto Y, Valdes-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, et al. Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the center for international blood and marrow transplant research and transplant complications working party of the European society of blood and marrow transplantation. Biol Blood Marrow Transplant. 2019;25(2):e46–e54.
   PubMedGoogle Scholar
• Kheirkhah A, Crnej A, Ren A, Mullins A, Satitpitakul V, Hamrah P, Schaumberg D, Dana R. Patients’ perceived treatment effectiveness in dry eye disease. Cornea. 2017;36:893–97.
   PubMed Web of Science ®Google Scholar
• Espana EM, Shah S, Santhiago MR, Singh AD. Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol. 2013;251:1257–66.
   PubMed Web of Science ®Google Scholar
• Choi W, Ha JY, Li Y, Choi JH, Ji YS, Yoon KC. Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sjogren’s syndrome. Int J Ophthalmol. 2019;12:393–400.
   PubMed Web of Science ®Google Scholar
• Kusne Y, Temkit M, Khera N, Patel DR, Shen JF. Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease. Ocul Surf. 2017;15:784–88.
   PubMed Web of Science ®Google Scholar
• Que L, Zhang X, Li M. Single-center retrospective study on meibomian gland loss in patients with ocular chronic graft-versus-host disease. Eye Contact Lens. 2018;44:S169–S175.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. 2018;59:DES192–DES199.
   PubMed Web of Science ®Google Scholar
• Amano S. Meibomian gland dysfunction: recent progress worldwide and in Japan. Invest Ophthalmol Vis Sci. 2018;59:87–93.
   Web of Science ®Google Scholar
• Hwang HS, Ha M, Kim HS, Na KS. Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease. Ocul Surf. 2019;17:464–69.
   PubMed Web of Science ®Google Scholar
• Ram R, Storb R. Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future. Leuk Lymphoma. 2013;54:1591–601.
   PubMed Web of Science ®Google Scholar
• Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant. 2014;49:168–73.
   PubMed Web of Science ®Google Scholar
• Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:604–11.
   PubMed Web of Science ®Google Scholar
• Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314:729–35.
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–49.
   PubMed Web of Science ®Google Scholar